EVOKE PHARMA
Live / Registered — Registered and renewed (as of 27 Aug 2024)
What this means for you
Registered since 17 Jun 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Jun 2024).
Record
- Serial number
- 85317211
- Registration number
- 4552076
- Mark type
- Stylized text
- Filed
- 10 May 2011
- Published for opposition
- 03 Apr 2012
- Registered
- 17 Jun 2014
- Next maintenance due
- 17 Jun 2024
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of gastrointestinal diseases
- Class 042 — Scientific and technological services: Scientific and medical research, scientific analysis and new product development in the field of pharmaceutical drugs
Owner
- Evoke Pharma, Inc., Solana Beach, CA, US
- Evoke Pharma, Inc., Solana Beach, CA, US
- Evoke Pharma, Inc., San Diego, CA, US
Prosecution history
- 27 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 27 Aug 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 27 Aug 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 27 Aug 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Jun 2024 — TEAS SECTION 8 & 9 RECEIVED
- 17 Jun 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 27 Mar 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Mar 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Mar 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Dec 2020 — TEAS SECTION 8 & 15 RECEIVED
- 17 Jun 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Jun 2014 — REGISTERED-PRINCIPAL REGISTER
- 13 May 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 May 2014 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 10 May 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED